News & Announcements


This project will standardize biomarkers that help diagnose Non-Alcoholic SteatoHepatitis (NASH) - a type of liver disease.

TB Vaccine

Through the new project, researchers will analyze the effects of delivering the only current TB vaccine intravenously in an attempt to better prevent TB.

David Fryburg Q&A

In this Q&A, David Fryburg, M.D.,Chair of the Beta Cell Project Team, discusses the results of this significant project as it comes to a close.


Kidney Safety

FNIH Biomarkers Consortium and Critical Path Institute achieve the first ever qualification of a clinical safety biomarker by the U.S. Food and Drug Administration.

Driven to Cure, Inc. President and CEO, Andrew Lee

Recipient of the 2018 Charles A. Sanders, M.D., Partnership Award, Andrew had an unwavering commitment to advancing biomedical research for rare kidney cancers. He was an inspiration to thousands across the country. The FNIH will remember him as an extraordinary young man who exemplified what one person can achieve with vision, determination, self-sacrifice and great spirit.

2019 NonProfit Pro Executive of the Year

FNIH President and Executive Director, Dr. Maria Freire, was recently named NonProfit Pro's 2019 Executive of the Year!



Front Page: